| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.48 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |